查找临床试验
已按「荨麻疹」检索，对应国际通用词 chronic urticaria
共找到 33 项正在招募的试验
数据更新于 00:19，每 5 分钟自动同步Mediterranean and Low-Histamine Diets for Pediatric Chronic Spontaneous Urticaria
Turkey (Türkiye)
年龄 12 Years – 18 Years
Saglik Bilimleri Universitesi
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
Denmark
年龄 18 Years – 不限
Simon Francis Thomsen
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
China
年龄 18 Years – 74 Years
Second Xiangya Hospital of Central South University
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
United States、Bulgaria、Canada、China、Germany 等 10 国
年龄 18 Years – 不限
Pfizer
Deployment o the Multidisciplinary Prospective Cohort Imminent
France
年龄 18 Years – 不限
University Hospital, Lille
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
Bulgaria、China、Poland、South Korea
年龄 18 Years – 75 Years
Yuhan Corporation
Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 Weeks
Hong Kong、Japan、South Korea
年龄 18 Years – 不限
Novartis Pharmaceuticals
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Netherlands
年龄 18 Years – 不限
Leiden University Medical Center
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
China
年龄 18 Years – 75 Years
Beijing InnoCare Pharma Tech Co., Ltd.
Remibrutinib in Real-world Clinical Practice
United States
年龄 18 Years – 不限
Novartis Pharmaceuticals
Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
China
年龄 18 Years – 不限
Jemincare
Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)
Germany
年龄 18 Years – 不限
Novartis Pharmaceuticals